Moximed springs to $33m Series B round

May 7, 2015 By Brad Perriello

Moximed said today that it pulled in a $33 million Series B round for its KineSpring knee implant, which is designed to reduce the load on the joint while sparing its anatomy.

The Hayward, Calif.-based company said new backer Vertex Venture Holdings joined prior investors New Enterprise Assoc., Gilde Healthcare Partners, Morgenthaler Ventures and GBS Venture Partners in the round.

Dr. Christopher Shen, Vertex’s U.S. healthcare head, is slated to join Moximed’s board as part of the funding, the company said. Moximed has raised $105 million total, including the Series B, a company spokesman told MassDevice.com.

"Vertex shares Moximed’s vision of the vast opportunity to make joint unloading a standard of care for osteoarthritis patients. A procedure that could potentially avoid or delay joint replacement and costly revision arthroplasty surgeries would appeal to all stakeholders: patients, surgeons, payers, and employers," Shen said in prepared remarks.

KineSpring is designed to be implanted under the skin along the knee joint in mild to moderate osteoarthritis patients who aren’t responding to pain meds and bracing but aren’t ready for a full-on knee implant, Moximed said. The device won CE Mark approval in the European Union in 2009 and is in an investigational device exemption trial called Soar in the U.S.

"We are excited to add Vertex as a new investor, and we gratefully appreciate the continued support of our previous investors. The new capital will support the company’s efforts to gain FDA approval of the KineSpring system and grow commercial sales in Europe," CEO Kevin Sidow said in a press release. "We continue to be encouraged by the relief brought to patients worldwide by the KineSpring System and by the strong interest in a joint preserving treatment that allows patients to maintain the lifestyle they expect and deserve."

How COVID-19 impacts FDA interactions with medical device manufacturers
By Stewart Eisenhart, Emergo Group The US Food and Drug Administration may revise performance goals and timelines set under the Medical Device User Fee Amendments IV (MDUFA IV) as emergency efforts targeting the coronavirus pandemic take up more of the agency’s time. Get the full story here at the Emergo Group’s blog. The opinions expressed… […]
Switchback Medical adds ‘sandbox approach’ to device testing
Contract manufacturer Switchback Medical (Maple Grove, Minn.) today announced that it has added a new division. Switchback BioSim Innovations offers functional dynamic biosimulator model development, cell culture services and physician training, according to the company. Biosimulator models use animal and human tissue to create functional models, such as a pumping heart with working valves to… […]
Smith College team wins ventilator design challenge
A team of Smith College engineering alumnae, staff and faculty has won the CoVent-19 Challenge to design a rapidly deployable ventilator to address shortages caused by the COVID-19 pandemic, particularly in developing countries. A dozen anesthesiology resident physicians from Massachusetts General Hospital kicked off the public challenge April 1, attracting 200 entries. The 30-person team… […]
FDA gives certain device makers more time to add UDIs
The FDA said today that it will grant manufacturers of Class 1 and unclassified medical devices and certain others more time to add unique device identifiers (UDIs) to their products. These companies will now have until Sept. 24, 2022 to comply with the agency’s UDI rule, including standard date formatting, labeling and Global Unique Device… […]
Eurofins launches 10-minute COVID-19 exposure testing device
Eurofins (Paris:ERF.PA) announced today that it launched its rapid point-of-care testing devices to identify past exposure to COVID-19. The serology-based, finger-prick tests detect antibodies with a sensitivity of 94.5% from 19 days following the onset of symptoms, with results coming in just 10 minutes, according to a news release. Get the full story at our sister site,… […]
How is RF technology shaping the future of medtech?
RF technology, including microwaves, isn’t just about wireless communications or military radar these days. Times Microwave Systems experts point out that it is increasingly important when it comes to medtech. Many medical electronics systems such as magnetic resonance imaging (MRI) systems for cancer detection rely on RF/microwave technology. Times Microwave Systems (Wallingford, Conn.) is hosting… […]
Medical device litigation and COVID-19: What you need to know
The COVID-19 pandemic is creating a new set of medical device litigation challenges — but also a chance for an industry reset. One of Greenberg Traurig’s top medtech litigation lawyers shares her insights. Sara Thompson doesn’t take any guff when she tells people that she defends medical device and pharmaceutical companies from lawsuits. “I say,… […]
Mayo Clinic needed to engineer its way through COVID-19: Here’s what they did.
The health system’s medical and engineering staffs had to devise their own solutions for lab gear, PPE and operating room air decontamination. As COVID-19 settles into several regions of the U.S., healthcare systems that once sat on the sidelines likely will find themselves in the same situation as their counterparts in the Northeast did earlier… […]
Xenco Medical launches porous spinal implant
Xenco Medical this week said it launched its Cancellex porous titanium lumbar interbodies. The injection-molded titanium foam spinal implants are designed to be pre-attached to disposable, composite polymer instruments. They feature interconnected porosity throughout each implant and are designed to promote bone apposition and facilitate vascularization Each implant is sterile packaged and comes pre-attached to… […]
Applied Plastics adds VP of sales
Applied Plastics (Norwood, Mass.) — maker of PTFE-coated products for advanced catheter systems — announced today that Michael Brown has joined the company as VP of sales and marketing. Brown will be responsible for global sales and marketing, including Applied Plastics’ new online store, which offers shipment within the U.S. and Europe. The company recently… […]
Heraeus Medical Components opens new Collaboration Hub outside Minneapolis
Heraeus Medical Components recently announced that it has opened a new nearly 67,000-square-foot Collaboration Hub in the Minneapolis-St. Paul medtech cluster. The Collaboration Hub — a completely new location near the Heraeus’ existing Fridley, Minn. facility — is meant to provide the company’s customers with the opportunity to work on-site with Heraeus Medical component R&D… […]